Anti-CD2 and anti-CD3 monoclonal antibodies synergize to prolong allograft survival with decreased side effects (Q72216471)
Jump to navigation
Jump to search
scientific article published on 01 April 1993
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Anti-CD2 and anti-CD3 monoclonal antibodies synergize to prolong allograft survival with decreased side effects |
scientific article published on 01 April 1993 |
Statements
Anti-CD2 and anti-CD3 monoclonal antibodies synergize to prolong allograft survival with decreased side effects (English)
K D Chavin
L Qin
J Lin
A J Kaplan
1 April 1993